Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125725731 | 12572573 | 1 | I | 20160629 | 20160720 | 20160720 | EXP | CA-AMGEN-CANSL2016086149 | AMGEN | 0.00 | F | Y | 0.00000 | 20160719 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125725731 | 12572573 | 1 | PS | PROLIA | DENOSUMAB | 1 | Unknown | UNK | U | 125320 | SOLUTION FOR INJECTION | ||||||||
| 125725731 | 12572573 | 2 | C | HYZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
| 125725731 | 12572573 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125725731 | 12572573 | 1 | Osteopenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125725731 | 12572573 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125725731 | 12572573 | Cataract operation | |
| 125725731 | 12572573 | Diarrhoea | |
| 125725731 | 12572573 | Drug intolerance | |
| 125725731 | 12572573 | Fatigue | |
| 125725731 | 12572573 | Meibomian gland dysfunction | |
| 125725731 | 12572573 | Myalgia | |
| 125725731 | 12572573 | Off label use | |
| 125725731 | 12572573 | Somnolence | |
| 125725731 | 12572573 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |